Search

Your search keyword '"Johnson, Cassandra"' showing total 135 results

Search Constraints

Start Over You searched for: Author "Johnson, Cassandra" Remove constraint Author: "Johnson, Cassandra" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
135 results on '"Johnson, Cassandra"'

Search Results

1. Red crusty plaques in a young man

2. SARS-CoV-2 shedding and evolution in patients who were immunocompromised during the omicron period: a multicentre, prospective analysis

5. Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged [greater than or equal to]18 Years--VISION and IVY Networks, September 2023- January 2024

6. Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity — IVY Network, 26 Hospitals, October 18, 2023–March 9, 2024

9. Food Insecurity Associated with Higher Stress, Depressive Symptoms, and Lower Diet Quality among Women Caregivers in North Carolina.

12. 1108. Severity of Illness among Adults Hospitalized with Respiratory Syncytial Virus Compared with COVID-19 and Influenza — IVY Network, 25 Hospitals, 20 U.S. States, January 31, 2022 – April 11, 2023

13. 1097. A Prospective Evaluation of SARS-CoV-2 Shedding and Evolution in Immunocompromised Hosts During the Omicron Period — IVY Network, 5 U.S. States, April 11, 2022 – February 1, 2023

15. Superficial CD34 fibroblastic tumors and PRDM10‐rearranged soft tissue neoplasm: An evolving diagnosis.

16. SARS-CoV-2 shedding and evolution in immunocompromised hosts during the Omicron period: a multicenter prospective analysis

23. Supplementary Tables 1-4 from Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non–Small Cell Lung Cancer Treated with Chemotherapy

24. Supplementary Figure 3C from Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non–Small Cell Lung Cancer Treated with Chemotherapy

25. Supplementary Figure 2B from Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non–Small Cell Lung Cancer Treated with Chemotherapy

26. Supplementary Figure 1C from Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non–Small Cell Lung Cancer Treated with Chemotherapy

27. Data from Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non–Small Cell Lung Cancer Treated with Chemotherapy

28. Supplementary Figure 4A from Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non–Small Cell Lung Cancer Treated with Chemotherapy

32. A Review of Cutaneous Diseases Observed in Solid Organ Transplant Recipients

38. Skin of color representation in medical education: An analysis of National Board of Medical Examiners' self-assessments and popular question banks

39. Kaposi Sarcoma of the Face Not Associated with Acquired Immunodeficiency Syndrome: A Case Report and Review of the Literature

41. THE ADMINISTRATIVE TRINITY: A VALUE BASED SOLUTION TO POLICE REFORM IN THE UNITED STATES

44. Sclerosing perineurioma: a rare benign tumor in a pediatric patient.

46. Toxic epidermal necrolysis‐like cutaneous toxicity following chimeric antigen receptor T‐cell therapy in recurrent large B‐cell lymphoma.

47. Empagliflozin in Patients with Chronic Kidney Disease

49. Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity-IVY Network, 26 Hospitals, October 18, 2023-March 9, 2024.

50. Association of Hyperoxia During Cardiopulmonary Bypass and Postoperative Delirium in the Pediatric Cardiac ICU.

Catalog

Books, media, physical & digital resources